Novo Nordisk launches ’Break the Partnership’ campaign

The campaign aims to spread awareness across key stakeholders and encourage exploration of innovative and progressive medical solutions for weight management in diabetes

Novo Nordisk has partnered with former Indian cricket team captain and fitness enthusiast Kapil Dev to launch ‘Break the Partnership’ – a campaign aimed at educating people with diabetes (PwD), their caregivers, and doctors about the grave influence of weight in type 2 diabetes (T2D). The campaign encourages people with diabetes to consult clinicians on newer treatment options that help manage both blood glucose as well as weight in T2D.

The campaign aims to spread awareness across key stakeholders and encourage exploration of innovative and progressive medical solutions for weight management in diabetes. In the approaching 6 months, the Novo Nordisk team and its partners will engage healthcare professionals via awareness events and scientific meetings across multiple cities. Additionally, focused patient camps will be organised to diagnose, consult, and spread awareness on the subject.

Announcing the launch of the campaign, Kapil Dev said “I am glad to join Novo Nordisk in its effort to fight against diabetes. The ‘Break the Partnership’ #WeightinDiabetes campaign focuses on spreading awareness on the harmful association of diabetes and weight, which must be tackled with utmost importance. In cricket, a partnership between two batsmen can be very damaging for the opposing team, and a bowler is always looking to end it sooner than later. Similarly, the partnership of weight and diabetes can be injurious for patients and must be managed in time.  It is important to bowl out impending complications before they stump you. Advances in science today allow for effective treatment options in type 2 diabetes that help with both blood sugar control as well as weight management. As a person with type 2 diabetes, I know that diabetes can be managed efficiently if we act in time and adhere to the right medication. I suggest and highly recommend that patients talk to their doctor about newer and progressive treatment options available for type 2 diabetes.”

 

 

CSR activitiesDiabetesNovo Nordisk
Comments (0)
Add Comment